Corticosteroid Responsiveness Assessed in Patients with Chronic Cough
The most common presenting complaints included shortness of breath, rhinorrhea, and hoarseness.
All articles by Cassandra Pardini, PharmD
Survey Shows High Level of Parental Hesitancy for COVID-19 Vaccines
The survey asked about the likelihood of both child and parental vaccination, perceptions about the vaccines and the level of trust in various sources of information.
SCIT vs SLIT for Allergic Rhinitis: Efficacy Outcomes Compared
Both treatment options were found to be effective for adults with allergic rhinitis or rhinoconjunctivitis.
Removal of EHR Warning Linked to Increase in Cephalosporin Use in Patients With Penicillin Allergy
After removal of the warning, cephalosporin use increased from 17.9% to 27.0% at the intervention site.
Most Individuals Complete COVID-19 Vaccine Series, Says Report
The recommended time interval between the 2 doses is 21 days for the Pfizer-BioNTech vaccine and 28 days for the Moderna vaccine; however, if a delay is unavoidable, 42 days between doses is considered permissible.
Case Series Describes Use of Icosapent Ethyl for COVID-19 Pneumonia
The authors described the cases of 3 patients with moderate to severe COVID-19 pneumonia who were treated with 2g of icosapent ethyl administered twice daily via a nasogastric tube.
Fluvoxamine Evaluated in Patients With Mild COVID-19
The study, which was fully remote and contactless, aimed to evaluate whether early treatment with fluvoxamine reduced the likelihood of clinical deterioration and disease severity in patients with mild COVID-19 illness.
Survey Reveals Factors Contributing to COVID-19 Vaccine Acceptance
To estimate the association between attribute level and probability of choosing and receiving a vaccine, the study authors calculated the average marginal component effects sizes as well as marginal means.
Management of Remdesivir-Associated Acute Liver Failure Examined in Case Series
Remdesivir was immediately discontinued in both patients and a continuous infusion of acetylcysteine was initiated.
Study Findings Do Not Support Use of Lopinavir-Ritonavir for COVID-19
The RECOVERY trial is the first randomized controlled trial to report on the effects of lopinavir-ritonavir in hospitalized COVID-19 patients.
- Loading...
Loading...
Next post in Lung Infection
Loading... 
Loading...